Oral immunogenicity of potato-derived antigens to Mycobacterium tuberculosis in mice

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 10, 2012, Pages 823-830

  Zhang, Yi ^a   Chen, Suting ^a   Li, Jiayun ^a   Liu, Yuan ^a   Hu, Yuanlei ^a   Cai, Hong ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

mucosal delivery; transgenic plants; tuberculosis vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOUSE; MYCOBACTERIUM TUBERCULOSIS; ORAL DRUG ADMINISTRATION; POTATO; T LYMPHOCYTE; TRANSGENIC PLANT; TUBERCULOSIS; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PLANTS, GENETICALLY MODIFIED; SOLANUM TUBEROSUM; T-LYMPHOCYTES; TUBERCULOSIS; TUBERCULOSIS VACCINES;

BACTERIA (MICROORGANISMS); MUS; MYCOBACTERIUM TUBERCULOSIS; SOLANUM TUBEROSUM;

EID: 84867006918     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms068     Document Type: Article

References (37)

1. Walmsley AM and Arntzen CJ. Plants for delivery of edible vaccines. Curr Opin Biotechnol 2000, 11: 126-129. (Pubitemid 30182304)
2. Arntzen C, Plotkin S and Dodet B. Plant-derived vaccines and antibodies: potential and limitations. Vaccine 2005, 23: 1753-1756. (Pubitemid 40331839)
3. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS and Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 2001, 98: 11539-11544. (Pubitemid 32928764)
4. Dus Santos MJ, Carrillo C, Ardila F, Ríos RD, Franzone P, Piccone ME and Wigdorovitz A, et al. Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 2005, 23: 1838-1843. (Pubitemid 40331855)
5. Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ and Mason HS. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 2006, 24: 2506-2513. (Pubitemid 43290380)
6. Rigano MM, Dreitz S, Kipnis AP, Izzo AA and Walmsley AM. Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine. Vaccine 2006, 24: 691-695. (Pubitemid 43017836)
7. WHO. Global tuberculosis control: WHO report 2011. Geneva: World Health Organization, 2011.
8. Kaufmann SH. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect Dis 2011, 11: 633-640.
9. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M and Weissman D, et al. HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010, 181: 80-86.
10. Trunz BB, Fine P and Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006, 367: 1173-1180.
11. Content J, de la Cuvellerie A, De Wit L, Vincent-Levy-Frebault V, Ooms J and De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 1991, 59: 3205-3212.
12. Mason HS and Arntzen CJ. Transgenic plants as vaccine production systems. Trends Biotechnol 1995, 13: 388-392.
13. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM and Arntzen CJ. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 2000, 182: 302-305. (Pubitemid 30497819)
14. Thanavala YY and Lugade AA. Oral transgenic plant-based vaccine for hepatitis B. Immunol Res 2010, 46: 4-11.
15. Pavot V, Rochereau N, Genin C, Verrier B and Paul S. New insights in mucosal vaccine development. Vaccine 2012, 30: 142-154.
16. Mestecky JJ, Nguyen HH, Czerkinsky CC and Kiyono HH. Oral immunization: an update. Curr Opin Gastroenterol 2008, 24: 713-719.
17. Pascual DW. Vaccines are for dinner. Proc Natl Acad Sci USA 2007, 104: 10757-10758. (Pubitemid 47175174)
18. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009, 27: 393-422.
19. Andersen P and Doherty TM. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005, 3: 656-662. (Pubitemid 41052152)
20. Anderson DH, Harth G, Horwitz MA and Eisenberg D. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol 2001, 307: 671-681. (Pubitemid 33027684)
21. Stanley SA, Raghavan S, Hwang WW and Cox JS. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci USA 2003, 100: 13001-13006. (Pubitemid 37340015)
22. Morris S, Kelley C, Howard A, Li Z and Collins F. The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 2000, 18: 2155-2163. (Pubitemid 30129106)
23. Yu DH, Li M, Hu XD and Cai H. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector. Vaccine 2007, 25: 6744-6754. (Pubitemid 47332727)
24. Tian X, Cai H and Zhu YX. Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64. Acta Biochim Biophys Sin 2004, 36: 269-276. (Pubitemid 39107292)
25. Hall LJ, Clare S, Pickard D, Clark SO, Kelly DL and El Ghany MA. Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein. Vaccine 2009, 27: 6894-6904.
26. Huang JM, Sali M, Leckenby MW, Radford DS, Huynh HA, Delogu G and Cranenburgh RM, et al. Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector. Vaccine 2010, 28: 7523-7528.
27. Cai H, Tian X, Hu XD, Zhuang YH and Zhu YX. Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis. DNA Cell Biol 2004, 23: 450-456. (Pubitemid 38981979)
28. Wang X, Li X, Deng X, Han H, Shi W and Li Y. A protein extraction method compatible with proteomic analysis for the euhalophyte Salicornia europaea. Electrophoresis 2007, 28: 3976-3987. (Pubitemid 350143137)
29. Hu XD, Chen ST, Yu DH, Li SX and Cai H. Immunotherapy with combined DNA vaccines is an effective treatment for M. bovis infection in cattle. Vaccine 2009, 27: 1317-1322.
30. Hu XD, Yu DH, Chen ST, Li SX and Cai H. A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle. DNA Cell Biol 2009, 28: 191-199.
31. Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH and Hill AV. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 2003, 171: 1602-1609. (Pubitemid 36900097)
32. Chen L, Wang J, Zganiacz A and Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun 2004, 72: 238-246. (Pubitemid 38018181)
33. Calarota SA and Weiner DB. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants. Immunol Rev 2004, 199: 84-99. (Pubitemid 38736766)
34. Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K and Zganiacz A. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 2004, 173: 6357-6365. (Pubitemid 39487795)
35. Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M and Xing Z. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol 2005, 174: 7986-7994. (Pubitemid 40806309)
36. Derrick SC, Repique C, Snoy P, Yang AL and Morris S. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis. Infect Immun 2004, 72: 1685-1692. (Pubitemid 38263792)
37. de Valliere S, Abate G, Blazevic A, Heuertz RM and Hoft DF. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infect Immun 2005, 73: 6711-6720. (Pubitemid 41368837)